DHR240705P215000
- 0.05
- 0.000.00%
Danaher Newsroom
Unusual Options Activity: BCS, DLTR and Others Attract Market Bets, BCS V/OI Ratio Reaches 69.4
EST Jul 5th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends
Danaher Is Maintained at Outperform by Evercore ISI Group
Danaher Is Maintained at Outperform by Evercore ISI Group
Danaher Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/02/2024 7.78% Evercore ISI Group $266 → $260 Maintains Outperform 04/24/2024 20.21% Citigroup $280 → $2
Evercore Maintains Danaher(DHR.US) With Buy Rating, Maintains Target Price $260
Evercore analyst Vijay Kumar maintains $Danaher(DHR.US)$ with a buy rating, and maintains the target price at $260.According to TipRanks data, the analyst has a success rate of 47.4% and a total avera
Evercore ISI Cuts Price Target on Danaher to $260 From $266, Maintains Outperform Rating
Danaher (DHR) has an average rating of outperform and price targets ranging from $220 to $300, according to analysts polled by Capital IQ. Price: 242.50, Change: -2.01, Percent Change: -0.82
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks just under the surface and warrant attention.Investors are constantly o
Barclays Maintains Danaher(DHR.US) With Hold Rating, Maintains Target Price $270
Barclays analyst Luke Sergott maintains $Danaher(DHR.US)$ with a hold rating, and maintains the target price at $270.According to TipRanks data, the analyst has a success rate of 40.5% and a total ave
FDA Approves Danaher Unit's Rapid Test for Hepatitis C
By Paul Ziobro The Food and Drug Administration on Thursday granted marketing approval to Danaher's Cepheid unit for a rapid test for hepatitis C. The approval is for Cepheid's Xpert HCV test and Ge
FDA Grants Marketing Authorization To Cepheid For Xpert HCV Test And GeneXpert Xpress System, First Point-Of-Care Hepatitis C Test
FDA Grants Marketing Authorization To Cepheid For Xpert HCV Test And GeneXpert Xpress System, First Point-Of-Care Hepatitis C Test
Danaher To Go Ex-Dividend On June 28th, 2024 With 0.27 USD Dividend Per Share
June 26th (Eastern Time) - $Danaher(DHR.US)$ is trading ex-dividend on June 28th, 2024.Shareholders of record on June 28th, 2024 will receive 0.27 USD dividend per share on July 26th, 2024. The ex-div
Did Danaher Corporation (DHR) Get a Good Analyst Rating for Its Q1 Performance?
Danaher Corporation's (NYSE:DHR) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
It is hard to get excited after looking at Danaher's (NYSE:DHR) recent performance, when its stock has declined 3.0% over the past month. However, stock prices are usually driven by a company's fina
Integrated DNA Technologies Introduces New HIV Panel to Advance Virology Research
xGen HIV Amplicon Panel provides a single-tube, 2.5-hour workflow designed to enable detection down to 1,000 viral genome copiesCORALVILLE, Iowa--(BUSINESS WIRE)--#Amplicon--Global genomics solutions
Danaher Schedules Second Quarter 2024 Earnings Conference Call
WASHINGTON, June 24, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2024 on Tuesday, July 23, 2024 be
If You Invested $100 In This Stock 10 Years Ago, You Would Have $500 Today
Danaher (NYSE:DHR) has outperformed the market over the past 10 years by 6.07% on an annualized basis producing an average annual return of 16.87%. Currently, Danaher has a market capitalization of $1
The Zacks Analyst Blog Highlights Walmart, Exxon Mobil, Danaher and GSI Technology
Top Stock Reports for Walmart, Exxon Mobil & Danaher
Danaher On Track for Largest Percent Decrease Since April 2023 -- Data Talk
Danaher Corporation (DHR) is currently at $247.87, down $9.64 or 3.74% --Would be lowest close since May 6, 2024, when it closed at $247.40 --On pace for largest percent decrease since April 25, 202
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan